首页> The new microbiologica> Stenotrophomonas maltophilia infections: Could eravacycline be a new weapon for clinicians?

Stenotrophomonas maltophilia infections: Could eravacycline be a new weapon for clinicians?

导出 LinkOut

翻译打印收藏纠错

第一作者： Simone,Giuliano

第一单位： Infectious Diseases Division, Department of Medicine (DMED), University of Udine and Azienda Sanitaria Universitaria Friuli Centrale (ASUFC), Udine, Italy.

作者： Simone,Giuliano ^[1] ; Luca,Martini ^[1] ; Francesca,Prataviera ^[1] ; Chiara,Moreal ^[2] ; Sarah,Flammini ^[1] ; Davide,Lazzarotto ^[3] ; Giovanni,Terrosu ^[4] ; Lucio,De Cecchis ^[5] ; Renato,Fanin ^[3] ; Carlo,Tascini ^[1]

作者单位： Infectious Diseases Division, Department of Medicine (DMED), University of Udine and Azienda Sanitaria Universitaria Friuli Centrale (ASUFC), Udine, Italy. ^[1] Department of Medicine (DMED), University of Udine and Azienda Sanitaria Universitaria Friuli Centrale (ASUFC), Udine, Italy. ^[2] Division of Hematology and Stem Cell Transplantation, University of Udine and Azienda Sanitaria Universitaria Friuli Centrale (ASUFC), Udine, Italy. ^[3] Department of Surgery, University Hospital "Santa Maria della Misericordia", Udine, Italy. ^[4] Department of Surgery, University of Udine, Italy. ^[5]

关键词 AML BSI Stenotrophomonas maltophilia eravacycline

医学主题词人类(Humans);抗菌药(Anti-Bacterial Agents);革兰氏阴性菌感染(Gram-Negative Bacterial Infections);免疫减弱宿主(Immunocompromised Host);嗜麦芽窄食单胞菌(Stenotrophomonas maltophilia);四环素类(Tetracyclines)

PMID 41140234

发布时间 2025-12-11

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交